Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study
This multi-centre, randomised study included 47 Russian cities, 350 internists, and 1050 patients with uncontrolled treated arterial hypertension (AH). The study aimed at multiple risk factor correction, to reduce total cardiovascular risk level, assessed by the SCORE scale. Antihypertensive therapy...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2009-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1506 |
_version_ | 1827064009849831424 |
---|---|
author | R. G. Oganov D. V. Nebieridze S. A. Shalnova A. M. Kalinina A. S. Safaryan А. D. Deev |
author_facet | R. G. Oganov D. V. Nebieridze S. A. Shalnova A. M. Kalinina A. S. Safaryan А. D. Deev |
author_sort | R. G. Oganov |
collection | DOAJ |
description | This multi-centre, randomised study included 47 Russian cities, 350 internists, and 1050 patients with uncontrolled treated arterial hypertension (AH). The study aimed at multiple risk factor correction, to reduce total cardiovascular risk level, assessed by the SCORE scale. Antihypertensive therapy was combined with educating education in Health Schools, targeting such risk factors as dyslipidemia, smoking, and overweight or obesity. The control group did not receive any educational intervention. For the first time, the electronic SCORE version was used in a clinical trial as a motivational tool to reduce total cardiovascular risk. The potential effectiveness of this instrument in clinical settings was evaluated. |
first_indexed | 2024-04-10T03:39:14Z |
format | Article |
id | doaj.art-3b8c492b71104107bd8db1a89d9b7327 |
institution | Directory Open Access Journal |
issn | 1728-8800 2619-0125 |
language | Russian |
last_indexed | 2025-03-19T22:40:20Z |
publishDate | 2009-12-01 |
publisher | «SILICEA-POLIGRAF» LLC |
record_format | Article |
series | Кардиоваскулярная терапия и профилактика |
spelling | doaj.art-3b8c492b71104107bd8db1a89d9b73272024-10-17T12:21:28Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252009-12-018650531224Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 StudyR. G. Oganov0D. V. Nebieridze1S. A. Shalnova2A. M. Kalinina3A. S. Safaryan4А. D. Deev5State Research Centre for Preventive Medicine, Federal Agency on High Medical TechnologiesState Research Centre for Preventive Medicine, Federal Agency on High Medical TechnologiesState Research Centre for Preventive Medicine, Federal Agency on High Medical TechnologiesState Research Centre for Preventive Medicine, Federal Agency on High Medical TechnologiesState Research Centre for Preventive Medicine, Federal Agency on High Medical TechnologiesState Research Centre for Preventive Medicine, Federal Agency on High Medical TechnologiesThis multi-centre, randomised study included 47 Russian cities, 350 internists, and 1050 patients with uncontrolled treated arterial hypertension (AH). The study aimed at multiple risk factor correction, to reduce total cardiovascular risk level, assessed by the SCORE scale. Antihypertensive therapy was combined with educating education in Health Schools, targeting such risk factors as dyslipidemia, smoking, and overweight or obesity. The control group did not receive any educational intervention. For the first time, the electronic SCORE version was used in a clinical trial as a motivational tool to reduce total cardiovascular risk. The potential effectiveness of this instrument in clinical settings was evaluated.https://cardiovascular.elpub.ru/jour/article/view/1506multi-centrerandomised studynoliprel®noliprel® fortetotal riskelectronic score version |
spellingShingle | R. G. Oganov D. V. Nebieridze S. A. Shalnova A. M. Kalinina A. S. Safaryan А. D. Deev Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study Кардиоваскулярная терапия и профилактика multi-centre randomised study noliprel® noliprel® forte total risk electronic score version |
title | Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study |
title_full | Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study |
title_fullStr | Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study |
title_full_unstemmed | Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study |
title_short | Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study |
title_sort | integrating modern antihypertensive therapy and patient education in real world clinical practice maximal reduction of total cardiovascular risk nocturne 2 study |
topic | multi-centre randomised study noliprel® noliprel® forte total risk electronic score version |
url | https://cardiovascular.elpub.ru/jour/article/view/1506 |
work_keys_str_mv | AT rgoganov integratingmodernantihypertensivetherapyandpatienteducationinrealworldclinicalpracticemaximalreductionoftotalcardiovascularrisknocturne2study AT dvnebieridze integratingmodernantihypertensivetherapyandpatienteducationinrealworldclinicalpracticemaximalreductionoftotalcardiovascularrisknocturne2study AT sashalnova integratingmodernantihypertensivetherapyandpatienteducationinrealworldclinicalpracticemaximalreductionoftotalcardiovascularrisknocturne2study AT amkalinina integratingmodernantihypertensivetherapyandpatienteducationinrealworldclinicalpracticemaximalreductionoftotalcardiovascularrisknocturne2study AT assafaryan integratingmodernantihypertensivetherapyandpatienteducationinrealworldclinicalpracticemaximalreductionoftotalcardiovascularrisknocturne2study AT addeev integratingmodernantihypertensivetherapyandpatienteducationinrealworldclinicalpracticemaximalreductionoftotalcardiovascularrisknocturne2study |